Bill Text: TX HB3482 | 2019-2020 | 86th Legislature | Introduced

---

Bill Title: Relating to the designation of centers of excellence for the early diagnosis and treatment of placental disorders.

Sponsorship: Partisan Bill (Republican 1)

Status: (Introduced - Dead) 2019-03-18 - Referred to Public Health [HB3482 Detail]

Download: Texas-2019-HB3482-Introduced.html

---

86R7807 JG-D
By: Davis of Harris H.B. No. 3482

A BILL TO BE ENTITLED
AN ACT
relating to the designation of centers of excellence for the early
diagnosis and treatment of placental disorders.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1. Chapter 32, Health and Safety Code, is amended by
adding Subchapter E to read as follows:
SUBCHAPTER E. CENTERS OF EXCELLENCE FOR EARLY DIAGNOSIS AND
TREATMENT OF PLACENTAL DISORDERS
Sec. 32.101. DEFINITION. In this subchapter, "placental
disorder" includes placenta accreta, placenta increta, and
placenta percreta.
Sec. 32.102. DESIGNATION OF CENTERS OF EXCELLENCE. (a) The
department, in consultation with the maternal mortality and
morbidity task force established under Chapter 34, shall designate
as centers of excellence for the early diagnosis and treatment of
placental disorders one or more health care entities or programs in
this state, including institutions of higher education or programs
of those institutions.
(b) The executive commissioner, in consultation with the
department and the maternal mortality and morbidity task force,
shall adopt rules necessary for a health care entity or program in
this state to be designated as a center of excellence for early
diagnosis and treatment of placental disorders.
Sec. 32.103. SUBCOMMITTEE. (a) The department, in
consultation with the maternal mortality and morbidity task force,
shall appoint a subcommittee of the task force to advise the
executive commissioner on the adoption of rules under Section
32.102. As part of the subcommittee's duties under this
subsection, the subcommittee specifically shall advise the
executive commissioner on the criteria necessary for a health care
entity or program in this state to receive a designation under this
subchapter.
(b) The subcommittee must consist of individuals with
expertise in the early diagnosis and treatment of placental
disorders. A majority of the members of the subcommittee must
practice in those areas in a health profession in this state. The
subcommittee may include national and international experts.
Sec. 32.104. PRIORITY CONSIDERATIONS FOR CENTER
DESIGNATIONS. The rules adopted under Section 32.102 must
prioritize awarding a designation under this subchapter to a health
care entity or program that:
(1) offers early diagnosis and treatment services for
placental disorders through a multi-specialty clinical program
that is affiliated and collaborates extensively with a medical
school in this state and an associated hospital that provides
advanced maternal and neonatal care in accordance with the
hospital's level of care designation received under Section
241.182;
(2) demonstrates a significant commitment to research
in and advancing the field of placental disorder care;
(3) offers advanced training programs in the early
diagnosis and treatment of placental disorders; and
(4) integrates an advanced placental disorder care
program with a program that provides appropriate long-term
monitoring and follow-up care for patients.
Sec. 32.105. REQUIREMENTS FOR DESIGNATION. The rules
adopted under Section 32.102 must ensure that a health care entity
or program in this state that receives a center of excellence
designation under this subchapter:
(1) provides or is affiliated with a hospital that
provides advanced maternal and neonatal care in accordance with the
hospital's level of care designation received under Section
241.182;
(2) implements and maintains a multidisciplinary
health care team, including maternal fetal medicine specialists,
pediatric and surgical specialists, neonatologists, nurses with
specialized maternal and neonatal training, and other ancillary and
support staff as appropriate to provide care related to placental
disorders;
(3) establishes minimum criteria for medical staff,
nursing staff, and ancillary and support staff;
(4) measures short-term and long-term patient
diagnostic and therapeutic outcomes; and
(5) provides to the department annual reports
containing aggregate data on short-term and long-term diagnostic
and therapeutic outcomes as requested or required by the department
and makes those reports available to the public on the entity's or
program's Internet website.
SECTION 2. (a) Not later than December 1, 2019, the
Department of State Health Services, in consultation with the
maternal mortality and morbidity task force established under
Chapter 34, Health and Safety Code, shall appoint members to the
subcommittee as required by Section 32.103, Health and Safety Code,
as added by this Act.
(b) Not later than December 1, 2020, the executive
commissioner of the Health and Human Services Commission shall
adopt rules as required by Section 32.102, Health and Safety Code,
as added by this Act.
(c) Not later than September 1, 2021, the Department of
State Health Services shall begin awarding designations of centers
of excellence as required by Subchapter E, Chapter 32, Health and
Safety Code, as added by this Act.
SECTION 3. This Act takes effect September 1, 2019.